649 related articles for article (PubMed ID: 27377963)
1. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
2. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
3. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
[TBL] [Abstract][Full Text] [Related]
4. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.
Tian HP; Lun SM; Huang HJ; He R; Kong PZ; Wang QS; Li XQ; Feng YM
J Biol Chem; 2015 Jul; 290(31):19173-83. PubMed ID: 26070560
[TBL] [Abstract][Full Text] [Related]
6. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.
Yu ZH; Lun SM; He R; Tian HP; Huang HJ; Wang QS; Li XQ; Feng YM
Cancer Lett; 2017 Aug; 402():142-152. PubMed ID: 28577976
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
[TBL] [Abstract][Full Text] [Related]
8. FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells.
Lo PK
Trends Diabetes Metab; 2018; 1(1):. PubMed ID: 30294731
[TBL] [Abstract][Full Text] [Related]
9. The controversial role of forkhead box F2 (FOXF2) transcription factor in breast cancer.
Lo PK
PRAS Open; 2017; 1():. PubMed ID: 29046905
[TBL] [Abstract][Full Text] [Related]
10. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract][Full Text] [Related]
12. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
13. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
14. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.
Lo PK; Lee JS; Liang X; Han L; Mori T; Fackler MJ; Sadik H; Argani P; Pandita TK; Sukumar S
Cancer Res; 2010 Jul; 70(14):6047-58. PubMed ID: 20587515
[TBL] [Abstract][Full Text] [Related]
16. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.
Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL
Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833
[TBL] [Abstract][Full Text] [Related]
17. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
[TBL] [Abstract][Full Text] [Related]
18. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
19. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]